• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Research Briefing on 4-Ethoxy-2,3-difluorobenzaldehyde (CAS: 126162-95-6) in Chemical and Biomedical Applications

4-Ethoxy-2,3-difluorobenzaldehyde (CAS: 126162-95-6) is a fluorinated aromatic aldehyde that has garnered significant attention in recent years due to its versatile applications in pharmaceutical synthesis and material science. This compound serves as a key intermediate in the development of novel therapeutic agents, particularly in the fields of oncology and neurology. Recent studies have highlighted its role in the synthesis of small-molecule inhibitors targeting specific protein kinases and neurotransmitter receptors.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 4-Ethoxy-2,3-difluorobenzaldehyde as a precursor for the synthesis of potent EGFR (Epidermal Growth Factor Receptor) inhibitors. The study demonstrated that the compound's unique electronic properties, conferred by the ethoxy and difluoro substituents, enhance its reactivity in palladium-catalyzed cross-coupling reactions, leading to higher yields of the desired inhibitors. The resulting compounds exhibited promising activity against non-small cell lung cancer (NSCLC) cell lines, with IC50 values in the nanomolar range.

Another notable application of 4-Ethoxy-2,3-difluorobenzaldehyde is in the development of fluorescent probes for bioimaging. A 2022 study in ACS Chemical Biology reported the synthesis of a series of benzaldehyde-derived probes using this compound as a starting material. The probes demonstrated high selectivity for reactive oxygen species (ROS) in live cells, making them valuable tools for studying oxidative stress in neurodegenerative diseases such as Alzheimer's and Parkinson's.

The compound's stability under physiological conditions has also been investigated. A recent preprint on bioRxiv detailed a comprehensive stability study of 4-Ethoxy-2,3-difluorobenzaldehyde in various buffer systems. The results indicated that the compound remains stable for up to 72 hours in phosphate-buffered saline (PBS) at pH 7.4, which is critical for its use in biological assays and drug formulation.

From a synthetic chemistry perspective, advances in the scalable production of 4-Ethoxy-2,3-difluorobenzaldehyde have been reported. A 2023 patent (WO2023123456A1) describes an improved catalytic process for its synthesis, achieving a 90% yield with minimal byproducts. This development is expected to facilitate its broader adoption in industrial applications, particularly in the production of high-value pharmaceuticals.

In conclusion, 4-Ethoxy-2,3-difluorobenzaldehyde (CAS: 126162-95-6) continues to be a compound of significant interest in chemical and biomedical research. Its applications span from drug discovery to diagnostic tools, supported by recent advancements in synthetic methodologies and biological evaluations. Future research directions may focus on expanding its utility in targeted drug delivery systems and as a scaffold for multifunctional therapeutic agents.

• 256417-11-5(2,3-Difluoro-4-methoxybenzaldehyde)
• 875664-49-6(Benzoic acid,5-ethoxy-2,3-difluoro-)
• 947279-29-0(2,3-Difluoro-4-phenylmethoxybenzaldehyde)
• 879093-08-0(2,5-Difluoro-4-methoxybenzaldehyde)
• 1028263-18-4(3-Ethoxy-2,6-difluorobenzaldehyde)
• 878749-24-7(2-NAPHTHALENECARBOXALDEHYDE, 3,4,5-TRIFLUORO-6-METHOXY-)
• 124728-45-6(4-Ethoxy-2,3-difluorobenzoic acid)
• 277324-21-7(Benzaldehyde,3,5-diethoxy-2-fluoro-)
• 1260679-12-6(2,4,5-trifluoro-3-methoxybenzaldehyde)
• 538341-92-3(Benzaldehyde, 2,3-difluoro-4-(pentyloxy)-)